Healthcare Industry News: radiation therapy
News Release - December 20, 2013
RaySearch Laboratories: License agreement with TomoTherapy terminatedSTOCKHOLM--(Healthcare Sales & Marketing Network)--In 2007, RaySearch Laboratories AB (STO:RAYB) and TomoTherapy Incorporated (now Accuray) entered into a software licensing and development agreement. Under the agreement, RaySearch developed a product named SharePlan, which was launched by TomoTherapy in 2009.
SharePlan is an advanced treatment planning solution that enables transfer of treatment plans between TomoTherapy systems and conventional linear accelerators. The product uses highly sophisticated algorithms to automatically generate a selection of deliverable high-quality IMRT plans based on an existing TomoTherapy treatment plan. This time-saving concept is an important tool for optimizing patient benefit and throughput at clinics that have a mixed environment with both TomoTherapy systems and conventional linear accelerators.
Now RaySearch and Accuray have agreed to cancel the agreement and end the partnership. Although the partnership will be ending, Accuray and RaySearch are committed to ensuring that customer needs are supported and maintained. As a result, SharePlan functionality will continue to be available for new and existing customers as an integrated module in RaySearch’s RayStation® treatment planning system that is sold and marketed by RaySearch. Existing SharePlan customers will be offered a free upgrade to RayStation®.
“Since the original agreement was signed, a lot has changed for both companies so this solution makes good sense for both parties. RayStation® was not available four years ago so back then a stand-alone application was the best solution. Now however, we can offer the same functionality in RayStation® which is evolving very rapidly and also gives the TomoTherapy System users the option to select other features and advanced treatment planning tools. This is attractive for the customers and Accuray alike as it expands the product offering for these customers”, says Johan Löf, CEO of RaySearch.
RayStation® integrates all RaySearch’s advanced treatment planning solutions into a flexible treatment planning system. It combines unique features such as multi-criteria optimization tools with full support for 4D adaptive radiation therapy. It also includes functionality such as RaySearch’s market-leading algorithms for IMRT and VMAT optimization and highly accurate dose engines for photon, electron and proton therapy. The system is built on the latest software architecture and has a graphical user interface offering state-of-the-art usability.
RaySearch Laboratories is a medical technology company that develops advanced software solutions for improved radiation therapy of cancer. RaySearch’s products are mainly sold through license agreements with leading partners such as Philips, Nucletron, IBA, Varian, Accuray and Brainlab. To date, 15 products have been launched through partners and RaySearch’s software is used at over 2,300 clinics in more than 30 countries. In addition, RaySearch offers the proprietary treatment planning system RayStation® directly to clinics. RaySearch was founded in 2000 as a spin-off from Karolinska Institutet in Stockholm and the company is listed in the Small Cap segment on NASDAQ OMX Stockholm.
Source: RaySearch Laboratories
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.